The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serghides, L.
Right arrow Articles by Watts, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serghides, L.
Right arrow Articles by Watts, T. H.
The Journal of Immunology, 2005, 175: 6368-6377.
Copyright © 2005 by The American Association of Immunologists

Evaluation of OX40 Ligand as a Costimulator of Human Antiviral Memory CD8 T Cell Responses: Comparison with B7.1 and 4-1BBL1

Lena Serghides*, Jacob Bukczynski*, Tao Wen2,*, Chao Wang*, Jean-Pierre Routy{dagger}, Mohamed-Rachid Boulassel{dagger}, Rafick-Pierre Sekaly{ddagger}, Mario Ostrowski§, Nicole F. Bernard and Tania H. Watts3,*

* Department of Immunology, University of Toronto, Toronto, Ontario, Canada; {dagger} Immunodeficiency Service and Division of Hematology, Royal Victoria Hospital, and {ddagger} Departement de Microbiologie et Immunologie, Universite de Montreal, Montreal, Quebec, Canada; § Department of Medicine, St. Michael’s Hospital, University of Toronto, Ontario, Canada; and Research Institute of McGill University Health Center, Montreal, Quebec, Canada

CTL are important effectors of antiviral immunity. Designing adjuvants that can induce strong cytotoxic T cell responses in humans would greatly improve the effectiveness of an antiviral vaccination or therapeutic strategy. Recent evidence suggests that, in addition to its well-established role in costimulation of CD4 T cell responses, OX40L (CD134) can directly costimulate mouse CD8 T cells. In this study, we evaluated the role of OX40L in costimulation of human antiviral CD8 T cell responses and compared it with two other important costimulators, B7.1 (CD80) and 4-1BBL (CD137L). Delivery of OX40L to human monocytes using a recombinant replication-defective adenovirus led to greater expansion, up-regulation of perforin, enhanced cytolytic activity, and increased numbers of IFN-{gamma}- and TNF-{alpha}-producing antiviral memory CD8 T cells in cultures of total T cells. Synergistic or additive effects were observed when OX40L costimulation was combined with 4-1BBL (CD137L) or B7.1 (CD80) costimulation. In total T cell cultures, at low Ag dose, 4-1BBL provided the most potent costimulus for influenza-specific CD8 T cell expansion, followed by B7.1 (CD80) and then OX40L. For isolated CD8 T cells, 4-1BBL was also the most consistent costimulator, followed by B7.1. In contrast, OX40L showed efficacy in direct activation of memory CD8 T cells in only one of seven donors. Thus, OX40L costimulates human antiviral memory CD8 T cell responses largely through indirect effects and can enhance anti-influenza, anti-EBV, and anti-HIV responses, particularly in combination with 4-1BBL or B7.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. S. Kim, S. Kim-Schulze, D. W. Kim, and H. L. Kaufman
Host Lymphodepletion Enhances the Therapeutic Activity of an Oncolytic Vaccinia Virus Expressing 4-1BB Ligand
Cancer Res., November 1, 2009; 69(21): 8516 - 8525.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Henson, O. Franzese, R. Macaulay, V. Libri, R. I. Azevedo, S. Kiani-Alikhan, F. J. Plunkett, J. E. Masters, S. Jackson, S. J. Griffiths, et al.
KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
Blood, June 25, 2009; 113(26): 6619 - 6628.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhao, A. Song, R. Haque, F. Lei, L. Weiler, X. Xiong, Y. Wu, M. Croft, and J. Song
Cooperation between Molecular Targets of Costimulation in Promoting T Cell Persistence and Tumor Regression
J. Immunol., June 1, 2009; 182(11): 6744 - 6752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Mack, A. K. Lanham, B. E. Palmer, L. A. Maier, T. H. Watts, and A. P. Fontenot
4-1BB Enhances Proliferation of Beryllium-Specific T Cells in the Lung of Subjects with Chronic Beryllium Disease
J. Immunol., September 15, 2008; 181(6): 4381 - 4388.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Wang, T. Wen, J.-P. Routy, N. F. Bernard, R. P. Sekaly, and T. H. Watts
4-1BBL Induces TNF Receptor-Associated Factor 1-Dependent Bim Modulation in Human T Cells and Is a Critical Component in the Costimulation-Dependent Rescue of Functionally Impaired HIV-Specific CD8 T Cells
J. Immunol., December 15, 2007; 179(12): 8252 - 8263.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. C. P. Waller, N. McKinney, R. Hicks, A. J. Carmichael, J. G. P. Sissons, and M. R. Wills
Differential costimulation through CD137 (4 1BB) restores proliferation of human virus-specific "effector memory" (CD28 CD45RAHI) CD8+ T cells
Blood, December 15, 2007; 110(13): 4360 - 4366.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Petrovas, J. P. Casazza, J. M. Brenchley, D. A. Price, E. Gostick, W. C. Adams, M. L. Precopio, T. Schacker, M. Roederer, D. C. Douek, et al.
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
J. Exp. Med., October 2, 2006; 203(10): 2281 - 2292.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Ito, Y.-H. Wang, O. Duramad, S. Hanabuchi, O. A. Perng, M. Gilliet, F. X.-F. Qin, and Y.-J. Liu
OX40 ligand shuts down IL-10-producing regulatory T cells
PNAS, August 29, 2006; 103(35): 13138 - 13143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.